Eigen Therapeutics
Redwood City, US · 2 known investors
Find your way into Eigen Therapeutics
Sign up to find every way you can get introduced to Eigen Therapeutics
- Your email: who you already know at Eigen Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Eigen Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Eigen develops co-therapies that modulate cancer cell target expression to improve the effectiveness of targeted treatments such as antibody-drug conjugates and radioligand therapies. It uses a discovery platform combining machine learning, robotic automation, and high-throughput combinatorial screening to design combination therapies addressing tumor heterogeneity.
Investors · 2
Frequently asked questions
- What does Eigen Therapeutics do?
- Eigen develops co-therapies that modulate cancer cell target expression to improve the effectiveness of targeted treatments such as antibody-drug conjugates and radioligand therapies. It uses a discovery platform combining machine learning, robotic automation, and high-throughput combinatorial screening to design combination therapies addressing tumor heterogeneity.
- Who are Eigen Therapeutics's investors?
- Eigen Therapeutics's investors include SBXi, ZAKA VC.
- Where is Eigen Therapeutics headquartered?
- Eigen Therapeutics is headquartered in Redwood City, US.


